West Virginia HB 4626: Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Status: Vetoed by Governor 4/1/2026 (as of 2026-04-02)

State: West Virginia · Session: 2026 · Bill: HB 4626

Subjects: Health

Sponsors: Browning, Burkhammer, Dean, Heckert, Hillenbrand, Hite, Worrell

View West Virginia HB 4626 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.